Takeo Oshima

1.4k total citations · 1 hit paper
15 papers, 1.2k citations indexed

About

Takeo Oshima is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Takeo Oshima has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Takeo Oshima's work include Neuroscience and Neuropharmacology Research (3 papers), Estrogen and related hormone effects (3 papers) and Acute Ischemic Stroke Management (3 papers). Takeo Oshima is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Estrogen and related hormone effects (3 papers) and Acute Ischemic Stroke Management (3 papers). Takeo Oshima collaborates with scholars based in Japan and United Kingdom. Takeo Oshima's co-authors include David Attwell, David J. Rossi, Masayoshi Kumegawa, Shozo Yamamoto, Kazushige Yokota, Masami Kusaka, Kenji Asakura, Monique Sarantis, Ikuo Hırono and Yoshikazu Yuki and has published in prestigious journals such as Nature, Journal of the American Chemical Society and European Journal of Pharmacology.

In The Last Decade

Takeo Oshima

13 papers receiving 1.2k citations

Hit Papers

Glutamate release in severe brain ischaemia is mainly by ... 2000 2026 2008 2017 2000 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Glutamate release in severe brain ischaemia is mainly by reversed uptake
    2000 904 citations David J. Rossi, Takeo Oshima et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeo Oshima Japan 9 780 571 221 113 112 15 1.2k
Ross D. O’Shea Australia 22 783 1.0× 703 1.2× 243 1.1× 237 2.1× 226 2.0× 40 1.7k
Shaogang Qu China 24 602 0.8× 670 1.2× 251 1.1× 218 1.9× 176 1.6× 66 1.5k
Yvette Dehnes Norway 18 1.2k 1.5× 696 1.2× 201 0.9× 170 1.5× 246 2.2× 34 1.7k
Helena Cimarosti Brazil 26 439 0.6× 844 1.5× 247 1.1× 244 2.2× 80 0.7× 54 1.7k
Chien‐liang Glenn Lin United States 19 883 1.1× 1.1k 1.9× 235 1.1× 354 3.1× 254 2.3× 31 2.1k
A.W. Teelken Netherlands 15 542 0.7× 379 0.7× 128 0.6× 198 1.8× 144 1.3× 37 1.2k
Amanda L. Sheldon United States 7 621 0.8× 404 0.7× 133 0.6× 133 1.2× 125 1.1× 9 853
Marc‐André Martel United Kingdom 13 788 1.0× 876 1.5× 212 1.0× 225 2.0× 62 0.6× 15 1.4k
Anitsi Loaiza Chile 12 474 0.6× 490 0.9× 180 0.8× 180 1.6× 66 0.6× 12 930
Monique Sarantis United Kingdom 12 898 1.2× 712 1.2× 166 0.8× 146 1.3× 144 1.3× 17 1.2k

Countries citing papers authored by Takeo Oshima

Since Specialization
Citations

This map shows the geographic impact of Takeo Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Oshima more than expected).

Fields of papers citing papers by Takeo Oshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Oshima. The network helps show where Takeo Oshima may publish in the future.

Co-authorship network of co-authors of Takeo Oshima

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Oshima. A scholar is included among the top collaborators of Takeo Oshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Oshima. Takeo Oshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Oshima, Takeo, et al.. (2022). Treatment-resistant diabetic chorea manifesting with psychiatric symptoms: a case report. Neurocase. 28(5). 432–438. 2 indexed citations
2.
Inamasu, Joji, et al.. (2020). Clinical Characteristics of Driving-related Stroke Occurring as a Recurrent Stroke. Journal of Stroke and Cerebrovascular Diseases. 29(4). 104634–104634.
3.
Oshima, Takeo, et al.. (2019). Wilson’s disease presenting as Asperger syndrome. Rinsho Shinkeigaku. 59(9). 589–591.
4.
Inamasu, Joji, et al.. (2017). Clinical Characteristics of Stroke Occurring while Bathing. Journal of Stroke and Cerebrovascular Diseases. 26(7). 1462–1466. 1 indexed citations
5.
Inamasu, Joji, et al.. (2017). Lymphomatosis cerebri showing transient spontaneous regression. Neurology and Clinical Neuroscience. 5(3). 93–95. 1 indexed citations
6.
Inamasu, Joji, Masashi Nakatsukasa, Keita Mayanagi, et al.. (2017). Stroke while driving: Frequency and association with automobile accidents. International Journal of Stroke. 13(3). 301–307. 13 indexed citations
7.
Ito, Takaomi, Kazuyoshi Tomita, Hiroko Togame, et al.. (2010). Identification of glycosylated exendin-4 analogue with prolonged blood glucose-lowering activity through glycosylation scanning substitution. Bioorganic & Medicinal Chemistry Letters. 20(15). 4631–4634. 18 indexed citations
8.
Tomita, Kazuyoshi, Takaomi Ito, Masataka Fumoto, et al.. (2009). Chemoenzymatic Synthesis of Glycosylated Glucagon-like Peptide 1: Effect of Glycosylation on Proteolytic Resistance and in Vivo Blood Glucose-Lowering Activity. Journal of the American Chemical Society. 131(17). 6237–6245. 66 indexed citations
9.
Ooi, Ei Lin, Noel Verján, Takeo Oshima, et al.. (2008). Innate immunomodulation with recombinant interferon-α enhances resistance of rainbow trout (Oncorhynchus mykiss) to infectious hematopoietic necrosis virus. Developmental & Comparative Immunology. 32(10). 1211–1220. 56 indexed citations
10.
Asakura, Kenji, Yoshiyuki Matsuo, Takeo Oshima, et al.. (2000). ω-Agatoxin IVA-sensitive Ca2+ channel blocker, α-eudesmol, protects against brain injury after focal ischemia in rats. European Journal of Pharmacology. 394(1). 57–65. 11 indexed citations
11.
Rossi, David J., Takeo Oshima, & David Attwell. (2000). Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 403(6767). 316–321. 904 indexed citations breakdown →
12.
Billups, Brian, David J. Rossi, Takeo Oshima, et al.. (1998). Chapter 4 Physiological and pathological operation of glutamate transporters. Progress in brain research. 116. 45–57. 51 indexed citations
13.
Yamamoto, Shozo, Takeo Oshima, Tanihiro Yoshimoto, et al.. (1991). Regulation of prostaglandin E2 synthesis by cyclooxygenase induction in osteoblast MC3T3-E1. Journal of Bone and Mineral Metabolism. 9(2). 45–48. 3 indexed citations
14.
Kusaka, Masami, Takeo Oshima, Kazushige Yokota, Shozo Yamamoto, & Masayoshi Kumegawa. (1988). Possible induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1) by cAMP. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 972(3). 339–346. 22 indexed citations
15.
Kusaka, Masami, Takeo Oshima, Kazushige Yokota, Shozo Yamamoto, & Masayoshi Kumegawa. (1988). Possible induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1) by cAMP. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 972(3). 339–346. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ross D. O’Shea Breakdown of academic impact, for papers by Shaogang Qu Breakdown of academic impact, for papers by Yvette Dehnes Breakdown of academic impact, for papers by Helena Cimarosti Breakdown of academic impact, for papers by Chien‐liang Glenn Lin Breakdown of academic impact, for papers by A.W. Teelken Breakdown of academic impact, for papers by Amanda L. Sheldon Breakdown of academic impact, for papers by Marc‐André Martel Breakdown of academic impact, for papers by Anitsi Loaiza Breakdown of academic impact, for papers by Monique Sarantis
Rankless by CCL
2026